tiprankstipranks
Advertisement
Advertisement
Neuphoria Therapeutics Announces CEO Transition and Consulting Role
PremiumCompany AnnouncementsNeuphoria Therapeutics Announces CEO Transition and Consulting Role
7M ago
Neuphoria Therapeutics Shareholders Align on Key Proposals
Premium
Company Announcements
Neuphoria Therapeutics Shareholders Align on Key Proposals
8M ago
Neuphoria announces ISS recommends shareholders vote ‘FOR’ director nominees
Premium
The Fly
Neuphoria announces ISS recommends shareholders vote ‘FOR’ director nominees
8M ago
Neuphoria initiates strategic review, confirms receipt of indication of interest
PremiumThe FlyNeuphoria initiates strategic review, confirms receipt of indication of interest
9M ago
Neuphoria Therapeutics Declares Dividend Rights Plan
Premium
Company Announcements
Neuphoria Therapeutics Declares Dividend Rights Plan
9M ago
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
9M ago
Morning Movers: General Motors and RTX higher following Q3 reports
PremiumThe FlyMorning Movers: General Motors and RTX higher following Q3 reports
10M ago
Neuphoria Therapeutics downgraded to Neutral from Buy at Lucid Capital
Premium
The Fly
Neuphoria Therapeutics downgraded to Neutral from Buy at Lucid Capital
10M ago
Closing Bell Movers: DocGo soars after SteadyMD deal
Premium
The Fly
Closing Bell Movers: DocGo soars after SteadyMD deal
10M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100